SCHEMBL7738145

SCHEMBL7738145

O=C(CC1CCCCN1)Nc1ccc(C2CCCCC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MITF O75030 1/20 0.54
KLF5 Q13887 1/20 0.54
ALDH1A1 P00352 5/20 0.53
HPGD P15428 2/20 0.53
NPC1 O15118 3/20 0.51
USP2 O75604 1/20 0.51
RORC P51449 1/20 0.51
ADORA2A P29274 1/20 0.51
HDAC3 O15379 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
DEGS1 O15121 1/20 0.48
KHK P50053 1/20 0.47
HTR2C P28335 1/20 0.46
HTR2B P41595 1/20 0.46
RAB9A P51151 2/20 0.46
EPHX2 P34913 2/20 0.46
KMT2A Q03164 1/20 0.46
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7259516 0.83 EPHX2 (0.61) HPGDNPC1ADORA2AKHKRAB9A
SCHEMBL2029199 0.83 EPHX2 (0.61) HPGDNPC1ADORA2AKHKRAB9A
SCHEMBL13766425 0.82 SMN1; SMN2 (0.57) NPC1USP2ADORA2AKHKRAB9A
SCHEMBL13762191 0.81 ADORA2A (0.53) ALDH1A1NPC1ADORA2AKHKRAB9A
SCHEMBL3640239 0.80 ADORA2A (0.49) ALDH1A1NPC1USP2RORCADORA2A
SCHEMBL12598147 0.76 NAMPT (0.46) NPC1ADORA2ARAB9ATP53SMN1; SMN2
SCHEMBL517540 0.76 MITF (0.63) MITFKLF5ALDH1A1HPGDNPC1
SCHEMBL7735911 0.76 MITF (0.63) MITFKLF5ALDH1A1HPGDNPC1
SCHEMBL3824110 0.76 MITF (0.63) MITFKLF5ALDH1A1HPGDNPC1
SCHEMBL31148173 0.74 HTR2C (0.59) MITFKLF5ALDH1A1HPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6410792-B1 OBESITY DISEASES BAYER CORPORATION 2002-06-25 US disclosed
US-6048900-A FOR TREATING EATING DISORDERS, INSULIN RESISTANT DIABETES, HYPERTENSION, HYPERLIPEMIA BAYER CORPORATION (US) 2000-04-11 US disclosed
EP-0910565-A1 AMIDE DERIVATIVES AS SELECTIVE NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Bayer Corporation (US) 1999-04-28 EP disclosed
WO-1998035957-A1 AMIDE DERIVATIVES AS SELECTIVE NEUROPEPTIDE Y RECEPTOR ANTAGONISTS BAYER CORPORATION (US) 1998-08-20 WO disclosed